My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Maruti advances after foraying into high performance segment
Mar 06,2017

The introductory price of Baleno RS is Rs 8.69 lakh ex-showroom Delhi. The announcement was made after market hours on Friday, 3 March 2017.

Meanwhile, the S&P BSE Sensex was up 162.34 points or 0.56% at 28,994.79

On the BSE, 21,000 shares were traded on the counter so far as against the average daily volumes of 59,272 shares in the past one quarter. The stock had hit a high of Rs 5,979.35 and a low of Rs 5,910 so far during the day.

The stock had hit a record high of Rs 6,230.30 on 8 February 2017 and a 52-week low of Rs 3,418.80 on 8 April 2016. The stock had underperformed the market over the past 30 days till 3 March 2017, falling 4.12% compared with 2.15% rise in the Sensex. The scrip had, however, outperformed the market in past one quarter, advancing 16.24% as against Sensexs 9.92% rise.

The large-cap company has equity capital of Rs 151.04 crore. Face value per share is Rs 5.

Presenting the Baleno RS, Managing Director & CEO, Maruti Suzuki India, Kenichi Ayukawa said that Baleno RS is for the performance enthusiasts who seek more power, throttle response and excitement in their day-to-day driving.

Separately, Maruti Suzuki India after market hours on Friday, 3 March 2017 said its total production rose 15.12% to 1.37 lakh units in February 2017 over February 2016.

Maruti Suzuki Indias net profit rose 47.46% to Rs 1744.50 crore on 12.44% growth in net sales to Rs 16623.60 crore in Q3 December 2016 over Q3 December 2015.

Maruti Suzuki India is Indias biggest car maker in terms of market share. Japanese parent Suzuki Motor Corporation currently holds 56.21% stake in Maruti Suzuki India (as per the shareholding pattern as on 31 December 2016).

Powered by Capital Market - Live News

Intellect Design Arena corrects on profit booking
Mar 06,2017

Meanwhile, the S&P BSE Sensex was up 211.43 points, 0.73% to Rs 29,043.88.

On the BSE, 64,000 shares were traded on the counter so far as against the average daily volumes of 2.28 lakh shares in the past one quarter. The stock had hit a high of Rs 124.40 so far and a low of Rs 120.10 so far during the day.

The stock had hit a 52-week high 252.10 on 3 May 2016 and a 52-week low of Rs 107.75 on 15 February 2017.

The small-cap company has equity capital of Rs 50.56 crore. Face value per share is Rs 5.

Shares of Intellect Design Arena had rallied 10.39% in the preceding three trading session to settle at Rs 123.20 on Friday, 3 March 2017, from its closing of Rs 111.60 on 28 February 2017.

Intellect Design Arenas reported net loss of Rs 21.59 crore in Q3 December 2016, compared with net profit of Rs 0.35 crore in Q3 December 2015. Net sales fell 8.3% to Rs 124.89 crore in Q3 December 2016 over Q3 December 2015.

Intellect Design Arena is a digital technology product solutions provider to the banking and insurance industry, across global consumer banking, central banking, global transaction banking, risk, treasury & markets and insurance.

Powered by Capital Market - Live News

IndusInd Bank gains after adding new branch in Gurgaon
Mar 06,2017

The announcement was made after market hours on Friday, 3 March 2017.

Meanwhile, the S&P BSE Sensex was up 218.26 points or 0.76% at 29,045.98.

On the BSE, 5,480 shares were traded on the counter so far as against the average daily volumes of 86,131 shares in the past one quarter. The stock had hit a high of Rs 1,319.50 and a low of Rs 1,290.05 so far during the day. The stock had hit a record high of Rs 1,364.30 on 17 February 2017 and a 52-week low of Rs 881.20 on 4 March 2016.

The stock had underperformed the market over the past one month till 3 March 2017, sliding 0.16% compared with the Sensexs 2.1% rise. The scrip had, however, outperformed the market over the past one quarter, gaining 23.19% as against the Sensexs 9.92% rise.

The large-cap bank has equity capital of Rs 598.08 crore. Face value per share is Rs 10.

IndusInd Bank said that it had recently inaugurated a branch in Gurgaon, one of the leading financial and industrial hubs in India. With the inauguration of this branch, the bank now has 29 branches in Gurgaon city.

IndusInd Banks net profit rose 29.19% to Rs 750.64 crore on 22.9% growth in total income to Rs 4716.13 crore in Q3 December 2016 over Q3 December 2015.

IndusInd Bank is a leading private sector bank in India.

Powered by Capital Market - Live News

Shree Cement gains after winning coal linkage in Chhattisgarh
Mar 06,2017

The announcement was made after market hours on Friday, 3 March 2017.

Meanwhile, the S&P BSE Sensex was up 219 points or 0.76% at 29,051.45

On BSE, so far 44 shares were traded in the counter as against average daily volume of 2,536 shares in the past one quarter. The stock hit a high of Rs 16,223.40 and a low of Rs 16,117.95 so far during the day.

The stock had hit a record high of Rs 18,519 on 3 October 2016. The stock had hit a 52-week low of Rs 10,900 on 8 March 2016. The stock had underperformed the market over the past 30 days till 3 March 2017, rising 1.23% compared with 2.15% rise in the Sensex. The scrip had also underperformed the market in past one quarter, advancing 6% as against Sensexs 9.92% rise.

The large-cap company has equity capital of Rs 34.84 crore. Face value per share is Rs 10.

Shree Cement said that the company had participated in the auction for coal linkage from South Eastern Coalfields (a subsidiary of Coal India) for cement sector and won the coal linkage in Chhattisgarh. The coal linkage is for the companys cement plant at Raipur, Chhattisgarh, Shree Cement said.

Shree Cements net profit rose 0.72% to Rs 235.43 crore on 3.9% growth in total income to Rs 1978.97 crore in Q3 December 2016 over Q3 December 2015.

Shree Cement is focused on its core business of cement and power. Currently its manufacturing operations are spread over North and Eastern India across five states.

Powered by Capital Market - Live News

Bharti Airtel gains after combining operations with Millicom in Ghana
Mar 06,2017

The announcement was made after market hours on Friday, 3 March 2017.

Meanwhile, the BSE Sensex was up 185.49 points, or 0.64%, to 29,017.94.

On the BSE, 99,193 shares were traded in the counter so far, compared with average daily volumes of 2.26 lakh shares in the past one quarter. The stock had hit a high of Rs 363.75 and a low of Rs 357.35 so far during the day. The stock had hit a 52-week high of Rs 400.65 on 23 February 2017. The stock had hit a 52-week low of Rs 283.95 on 9 November 2016.

The stock had underperformed the market over the past one month till 3 March 2017, rising 0.55% compared with the Sensexs 2.1% rise. The scrip had, however, outperformed the market over the past one quarter, gaining 11.56% as against the Sensexs 9.92% rise.

The large-cap company has equity capital of Rs 1,998.70 crore. Face value per share is Rs 5.

Bharti Airtel and Millicom International Cellular SA announced that they have through their respective subsidiaries entered into an agreement for Tigo Ghana and Airtel Ghana to combine their operations in Ghana. As per the agreement, Airtel and Millicom would have equal ownership and governance rights in the combined entity.

The combined business would serve nearly 10 million customers, of which 5.6 million are data customers. It would cover more than 80% of Ghanas population with high speed data providing the widest 3G coverage across the country, and would have revenues close to $300 million, making it one of the largest communications companies in Ghana, Airtel said.

The transaction is subject to obtaining approvals from the relevant authorities in Ghana and the satisfaction of customary closing conditions.

Separately, Bharti said that subject to all requisite approvals, the board of directors on Sunday, 5 March 2017, approved the scheme of amalgamation between Telenor (India) Communications and Bharti Airtel and their respective shareholders and creditors. The scheme envisages the issuance and allotment of 5 fully paid up equity shares of face value Rs 5 of Airtel to Telenor South Asia Investment Pte. Limited, the shareholder of the Telenor India upon the scheme becoming effective.

Bharti Airtel had announced on 23 February 2017, that it entered into a definitive agreement with Telenor South Asia Investments (Telenor) to acquire Telenor (India) Communications (Telenor India).

Bharti Airtels consolidated net profit fell 54.5% to Rs 503.70 crore on 3% decline in net sales to Rs 23335.70 crore in Q3 December 2016 over Q3 December 2015.

Bharti Airtel is a leading global telecommunications company with operations in 17 countries across Asia and Africa.

Powered by Capital Market - Live News

HDIL gains after announcing divestment of stake in Excel Arcade
Mar 06,2017

The announcement was made on Saturday, 4 March 2017.

Meanwhile, the S&P BSE Sensex was up 177.37 points, or 0.62%, to 29,009.82

On BSE, so far 2.18 lakh shares were traded in the counter, compared with an average volume of 16.38 lakh shares in the past one quarter. The stock hit a high of Rs 69.55 and a low of Rs 68.50 so far during the day.

The stock hit a 52-week high of Rs 108.75 on 12 July 2016. The stock hit a 52-week low of Rs 52.25 on 27 December 2016. The stock had outperformed the market over the past 30 days till 3 March 2017, rising 6.06% compared with 2.15% rise in the Sensex. The scrip had also outperformed the market in past one quarter, advancing 13.66% as against Sensexs 9.92% rise.

The small-cap company has an equity capital of Rs 434 crore. Face value per share is Rs 10.

Housing Development and Infrastructure (HDIL) said that the finance committee of the board at its meeting held on 4 March 2017, decided to divest its 100% shareholding of its wholly owned subsidiary company Excel Arcade. HDIL was holding 19.54 lakh shares and had invested Rs 10.81 crore in that company. It was meant to be a special purpose vehicle for a project at Vikroli. Since the timeline for the project is uncertain, it was decided to divest the investment in the subsidiary company for Rs 17 crore, HDIL said.

HDILs consolidated net profit dropped 83.82% to Rs 16.23 crore on 64.63% decline in total income to Rs 116.44 crore in Q3 December 2016 over Q3 December 2015.

HDIL is a real estate development company, with significant operations in the Mumbai Metropolitan Region.

Powered by Capital Market - Live News

Dr Reddys Lab nudges higher after completing acquisition of Imperial Credit
Mar 06,2017

The announcement was made after market hours on Friday, 3 March 2017.

Meanwhile, the S&P BSE Sensex was up 182.82 points or 0.63% at 29,015.27.

On the BSE, 2,890 shares were traded on the counter so far as against the average daily volumes of 32,227 shares in the past one quarter. The stock had hit a high of Rs 2,890.50 and a low of Rs 2,870 so far during the day.

The stock had hit a 52-week high of Rs 3,689 on 20 July 2016 and a 52-week low of Rs 2,803.50 on 16 February 2017. The stock had underperformed the market over the past one month till 3 March 2017, sliding 8.58% compared with the Sensexs 2.1% rise. The scrip had also underperformed the market over the past one quarter, declining 9.67% as against the Sensexs 9.92% rise.

The large-cap company has equity capital of Rs 82.87 crore. Face value per share is Rs 5.

Dr Reddys Laboratories said that the acquisition process was consummated on receipt of applicable regulatory approvals. The company proposes to undertake the groups captive financial activities through this entity. The company paid consideration of Rs 2.05 crore for the acquisition.

Dr Reddys Laboratories consolidated net profit fell 15.9% to Rs 492.30 crore on 6.6% fall in net sales to Rs 3706.50 crore in Q3 December 2016 over Q3 December 2015.

Dr Reddys Laboratories is an integrated global pharmaceutical company.

Powered by Capital Market - Live News

Cipla gains after entering into agreements for divesting animal health business in South Africa
Mar 06,2017

The announcement was made on Saturday, 4 March 2017.

Meanwhile, the S&P BSE Sensex was up 86.06 points, or 0.3%, to 28,918.51.

On the BSE, so far 3,214 shares were traded in the counter, compared with average daily volumes of 94,093 shares in the past one quarter. The stock had hit a high of Rs 593.45 and a low of Rs 590.50 so far during the day.

The stock hit a 52-week high of Rs 621.90 on 6 February 2017. The stock hit a 52-week low of Rs 458.25 on 25 May 2016.

The large-cap pharmaceutical company has equity capital of Rs 160.89 crore. Face value per share is Rs 2.

Cipla announced that the company has entered into agreements, through its wholly owned subsidiary Inyanga Trading 386 Proprietary (Inyanga), with the group companies of Ascendis Health, South Africa for divesting its animal health business in South Africa and Sub-Saharan Africa.

Under the agreements, Cipla will divest its 100% stake in Cipla Agrimed Proprietary (Cipla Agrimed), South Africa and Cipla Vet Proprietary (Cipla Vet), South Africa. The total consideration of transaction would be ZAR 375 million with potential revision linked to FY2017 performance along with customary adjustment (within the price band of R250m and R500m) in relation working capital and net debt/cash adjustments. The deal is subject to customary closing conditions including approval from competition commission of South Africa and is expected to close in the next 3 months.

Cipla Agrimed operates in the farm animals segment, with sales mainly attributable to agricultural co-operatives and bulk farm purchasing organizations. Cipla Agrimed has a leading position in antimicrobials and endectocides in South Africa. Cipla Vet operates in the companion animal segment with sales primarily to wholesalers. Ascendis Health is a South Africa based health and care brands company operating in human, plant and animal health.

Paul Miller, CEO, Cipla South Africa said that Cipla has taken the strategic decision to divest and sell its veterinary division. In line with this new strategy, the company will increase its focus and efforts to advancing health care for all South Africans. By doing this, Cipla will have a more intensive approach to grow our portfolio of quality and affordable products, with an aim to provide an even broader range of pharmaceutical solutions in more therapeutic areas in the South African Healthcare sector.

Ciplas consolidated net profit rose 45.18% to Rs 374.83 crore on 15.64% rise in net sales to Rs 3550.02 crore in Q3 December 2016 over Q3 December 2015.

Cipla is a global pharmaceutical company. Its portfolio includes over 1000 products across wide range of therapeutic categories.

Powered by Capital Market - Live News

Jubilant FoodWorks extends Thursdays gains
Mar 03,2017

Meanwhile, the S&P BSE Sensex was down 15.44 points or 0.05% at 28,824.35.

On the BSE, 82,000 shares were traded on the counter so far as against the average daily volumes of 60,242 shares in the past one quarter. The stock had hit a high of Rs 1,060.20 and a low of Rs 1,025.50 so far during the day.

The stock had hit a 52-week high of Rs 1,347.65 on 27 April 2016 and a 52-week low of Rs 761 on 26 December 2016. It had outperformed the market over the past one month till 2 March 2017, gaining 12.3% compared with the Sensexs 2.17% rise. The scrip had also outperformed the market over the past one quarter, advancing 18.52% as against the Sensexs 9.95% rise.

The mid-cap company has equity capital of Rs 65.95 crore. Face value per share is Rs 10.

Shares of Jubilant FoodWorks have risen 5.05% in two trading sessions from its closing price of Rs 1,003.20 on 1 March 2017, on reports a foreign brokerage has upgraded its rating on the stock to buy with a target price of Rs 1,228. The stock had risen 3.24% to settle at Rs 1,035.75 yesterday, 2 March 2017.

Jubilant FoodWorks net profit fell 31.9% to Rs 19.97 crore on 3.9% growth in net sales to Rs 658.76 crore in Q3 December 2016 over Q3 December 2015.

Jubilant FoodWorks is part of Jubilant Bhartia group and Indias largest food service company with a network of Dominos Pizza restaurants pan India. The company & its subsidiary have the exclusive rights to develop and operate Dominos Pizza brand in India, Sri Lanka, Bangladesh and Nepal. The company also has exclusive rights for developing and operating Dunkin Donuts restaurants for India.

Powered by Capital Market - Live News

Zenotech Lab gains after board approves winding up of Nigerian subsidiary
Mar 03,2017

The announcement was made after market hours yesterday, 2 March 2017.

Meanwhile, the BSE Sensex was down 15.38 points, or 0.05%, to 28,824.41.

On the BSE, 3,473 shares were traded in the counter so far, compared with an average volume of 9,422 shares in the past one quarter. The stock had hit a high of Rs 39.40 and a low of Rs 38.25 so far during the day. The stock had hit a 52-week high of Rs 51.80 on 15 June 2016. The stock had hit a 52-week low of Rs 31.50 on 30 March 2016.

It had underperformed the market over the past one month till 2 March 2017, falling 10.21% compared with the Sensexs 2.17% rise. The scrip had also underperformed the market over the past one quarter, dropping 3.77% as against the Sensexs 9.95% rise.

The small-cap pharma company has an equity capital of Rs 34.43 crore. Face value per share is Rs 10.

Zenotech Laboratories reported net loss of Rs 5.25 crore in Q3 December 2016 compared with net loss of Rs 4.75 crore in Q3 December 2015.

Powered by Capital Market - Live News

Bharti Infratel jumps on reports of brokerage upgrade
Mar 03,2017

Meanwhile, the S&P BSE Sensex was down 28.67 points or 0.1% at 28,811.12.

On the BSE, 6.03 lakh shares were traded on the counter so far as against the average daily volumes of 2.28 lakh shares in the past one quarter. The stock had hit a high of Rs 310 and a low of Rs 293 so far during the day.

The stock had hit a 52-week high of Rs 412.55 on 28 July 2016 and a 52-week low of Rs 283.10 on 28 February 2017. It had underperformed the market over the past one month till 2 March 2017, sliding 0.79% compared with the Sensexs 2.17% rise. The scrip had also underperformed the market over the past one quarter, declining 24.9% as against the Sensexs 9.95% rise.

The large-cap company has equity capital of Rs 1849.61 crore. Face value per share is Rs 10.

The foreign brokerage reportedly feels that with recent sharp correction in Bharti Infratel stock, risks related to tenancy impact due to likely Vodafone-Idea merger are overdone now. These merger & acquisition (M&A) deals in telecom space would be a positive catalyst for Bharti Infratels growth and strengthen its position in the tower space in India, as per the brokerages view.

Shares of Bharti Infratel declined 10.1% at its closing price of Rs 289.90 yesterday, 2 March 2017, from its closing of Rs 322.40 on 15 February 2017.

On a consolidated basis, Bharti Infratels net profit rose 25.3% to Rs 620.40 crore on 9.6% growth in net sales to Rs 1530 crore in Q3 December 2016 over Q3 December 2015.

Bharti Infratel is one of the leading providers of tower and related infrastructure. It deploys, owns and manages telecom towers and communication structures, for various mobile operators.

Powered by Capital Market - Live News

Nalco jumps 17.14% in six sessions
Mar 03,2017

The announcement was made after market hours yesterday, 2 March 2017.

The stock has jumped 17.14% to its current ruling price of Rs 75.85 in six sessions, from a close of Rs 64.75 on 22 February 2017.

Meanwhile, the S&P BSE Sensex was down 55.43 points or 0.19% at 28,784.36.

On the BSE, 4.73 lakh shares were traded in the counter so far as against average daily volume of 5.96 lakh shares in the past one quarter. The stock had hit a high of Rs 77.05 and a low of Rs 74.50 so far during the day. The stock had hit a 52-week high of Rs 79.35 on 27 January 2017. The stock had hit a 52-week low of Rs 32.95 on 2 March 2016.

It had underperformed the market over the past one month till 2 March 2017, gaining 2.03% compared with the Sensexs 2.17% rise. The scrip had, however, outperformed the market over the past one quarter, advancing 38.84% as against the Sensexs 9.95% rise.

The large-cap company has equity capital of Rs 966.46 crore. Face value per share is Rs 5.

Similarly, the hydrate production at its refinery has also registered an increase of 6.8%. The hydrate production till February 2017 was 18.9 lakh tonnes as against 17.7 lakh tonnes for the same period in the previous year. At its aluminium smelter, cast metal production grew by 3.79% and the aluminium metal sales grew by 2.68%.

Separately, the companys board of directors has approved payment of interim dividend of Rs 2.80 per share for the financial year ending 31 March 2017. The announcement was made after market hours yesterday, 2 March 2017.

Meanwhile, as per recent reports, China had ordered aluminium and steel producers in 28 cities to slash output during winter, as Beijing intensifies its war on smog.

Nalcos net profit fell 2.7% to Rs 143.92 crore on 13.9% rise in net sales Rs 1963.81 crore in Q3 December 2016 over Q3 December 2015.

State-run National Aluminium Company (Nalco) has integrated and diversified operations in mining, metal and power. The Government of India (GoI) held 74.58% stake in the company (as per the shareholding pattern as on 31 December 2016).

Powered by Capital Market - Live News

Apollo Hospitals Enterprise leads losers on BSEs A group
Mar 03,2017

Apollo Hospitals Enterprise shed 4.48% to Rs 1,257 on reports of stake sale by a Malaysian sovereign fund. The stock topped the losers in A group. On the BSE, 6.38 lakh shares were traded on the counter so far as against the average daily volumes of 12,000 shares in the past two weeks.

Media reports suggested that Khazanah Berhads subsidiary Integrated (Mauritius) Healthcare Holdings offloaded shares of Apollo Hospitals Enterprise through block deals on the stock exchanges today, 3 March 2017. Integrated (Mauritius) Healthcare Holdings owned 10.85% stake in Apollo Hospitals Enterprise end December 2016.

Jain Irrigation Systems fell 3.3% at Rs 89.30. The stock was the second biggest loser in A group. On the BSE, 3.4 lakh shares were traded on the counter so far as against the average daily volumes of 3.03 lakh shares in the past two weeks.

Amtek Auto fell 3.05% at Rs 36.50. The stock was the third biggest loser in A group. On the BSE, 2.4 lakh shares were traded on the counter so far as against the average daily volumes of 7.55 lakh shares in the past two weeks.

NCC declined 2.84% at Rs 78.70. The stock was the fourth biggest loser in A group. On the BSE, 2.4 lakh shares were traded on the counter so far as against the average daily volumes of 7.55 lakh shares in the past two weeks.

Bajaj Finserv dropped 2.7% at Rs 3,783.15. The stock was the fifth biggest loser in A group. On the BSE, 7,239 shares were traded on the counter so far as against the average daily volumes of 18,000 shares in the past two weeks.

Powered by Capital Market - Live News

Volumes jump at Geometric counter
Mar 03,2017

Geometric clocked volume of 10.15 lakh shares by 13:46 IST on BSE, a 132.51-times surge over two-week average daily volume of 8,000 shares. The stock was up 0.75% at Rs 262.75.

Apollo Hospitals Enterprise notched up volume of 6.37 lakh shares, a 52.55-fold surge over two-week average daily volume of 12,000 shares. The stock was down 4.51% at Rs 1,256.50.

Vista Pharmaceuticals saw volume of 25.74 lakh shares, a 24.34-fold surge over two-week average daily volume of 1.06 lakh shares. The stock surged by its upper circuit limit of 20% at Rs 30.90.

Dhampur Sugar Mills clocked volume of 3.34 lakh shares, a 5.52-fold surge over two-week average daily volume of 60,000 shares. The stock jumped 10.53% at Rs 205.75.

Dwarikesh Sugar Industries saw volume of 2.29 lakh shares, a 5.35-fold rise over two-week average daily volume of 43,000 shares. The stock was up 7.48% at Rs 427.50.

Powered by Capital Market - Live News

Apollo Hospitals drops on reports of stake-sale by a foreign fund
Mar 03,2017

Meanwhile, the S&P BSE Sensex was down 85 points or 0.29% at 28,754.79.

On the BSE, 6.10 lakh shares were traded on the counter so far as against the average daily volumes of 9,335 shares in the past one quarter. The stock had hit a high of Rs 1,288 and a low of Rs 1,246 so far during the day.

The stock had hit a record high of Rs 1,544 on 2 March 2016 and a 52-week low of Rs 1,110.75 on 26 December 2016. It had outperformed the market over the past one month till 2 March 2017, gaining 6.88% compared with the Sensexs 2.17% rise. The scrip had, however, underperformed the market over the past one quarter, advancing 9.65% as against the Sensexs 9.95% rise.

The large-cap company has equity capital of Rs 69.56 crore. Face value per share is Rs 5.

Media reports suggested that Khazanah Berhads subsidiary Integrated (Mauritius) Healthcare Holdings offloaded shares of Apollo Hospitals Enterprise through block deals on the stock exchanges today, 3 March 2017. Integrated (Mauritius) Healthcare Holdings owned 10.85% stake in Apollo Hospitals Enterprise end December 2016.

Apollo Hospitals net profit fell 40.5% to Rs 72.83 crore on 17.9% growth in net sales to Rs 1680.61 crore in Q3 December 2016 over Q3 December 2015.

Apollo Hospitals is one of Asias largest healthcare groups.

Powered by Capital Market - Live News